sb 203580 has been researched along with Chronic Illness in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Albrecht, W; Kotschenreuther, DA; Laufer, SA; Wagner, GK | 1 |
Albrecht, W; Bauer, SM; Laufer, SA; Unger, A | 1 |
Choi, H; Dikalov, SI; Koch, SR; Lamb, FS; Mace, EH; Sherwood, ER; Stark, RJ | 1 |
Chen, J; Dong, J; Fu, C; Guo, Z; Li, N; Liu, Y; Wang, R; Wang, S; Yang, J; Yuan, Y; Zhang, Y | 1 |
Feng, XR; Liu, ZC; Lu, HD; Wang, B; Zhou, J; Zhou, LY | 1 |
Huang, Y; Xu, L; Yang, N; Yu, X; Yue, J; Zuo, P | 1 |
6 other study(ies) available for sb 203580 and Chronic Illness
Article | Year |
---|---|
Novel substituted pyridinyl imidazoles as potent anticytokine agents with low activity against hepatic cytochrome P450 enzymes.
Topics: Aminopyridines; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Cytochrome P-450 Enzyme System; Cytokines; Enzyme Inhibitors; Humans; Imidazoles; Interleukin-1; Isoenzymes; Leukocytes, Mononuclear; Liver; Mitogen-Activated Protein Kinases; Models, Molecular; p38 Mitogen-Activated Protein Kinases; Pyridines; Stereoisomerism; Structure-Activity Relationship; Tumor Necrosis Factor-alpha | 2003 |
Discovery of N-{4-[5-(4-Fluorophenyl)-3-methyl-2-methylsulfanyl-3H-imidazol-4-yl]-pyridin-2-yl}-acetamide (CBS-3595), a Dual p38α MAPK/PDE-4 Inhibitor with Activity against TNFα-Related Diseases.
Topics: Aminopyridines; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Cyclic Nucleotide Phosphodiesterases, Type 4; Drug Discovery; Humans; Imidazoles; Inflammation; Mitogen-Activated Protein Kinase 14; Phosphodiesterase 4 Inhibitors; Protein Kinase Inhibitors; Tumor Necrosis Factor-alpha | 2017 |
Endothelial nitric oxide synthase modulates Toll-like receptor 4-mediated IL-6 production and permeability via nitric oxide-independent signaling.
Topics: Capillary Permeability; Cells, Cultured; Chronic Disease; Endothelial Cells; Gene Expression Regulation, Enzymologic; Humans; Imidazoles; Interleukin-6; Lipopolysaccharides; MAP Kinase Signaling System; Nitric Oxide; Nitric Oxide Synthase Type III; p38 Mitogen-Activated Protein Kinases; Pyridines; Toll-Like Receptor 4; Vasculitis | 2018 |
Chronic intermittent hypobaric hypoxia provides vascular protection in the aorta of the 2-kidney, 1-clip rat model of hypertension.
Topics: Acetylcholine; Animals; Anthracenes; Aorta; Basic Helix-Loop-Helix Transcription Factors; Blood Pressure; Body Weight; Bone Morphogenetic Protein 4; Carrier Proteins; Chronic Disease; Disease Models, Animal; Endothelium, Vascular; Flavonoids; Hypertension; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Imidazoles; In Vitro Techniques; Kidney; Male; Nitric Oxide Synthase Type III; Nitroprusside; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; Rats, Sprague-Dawley; Surgical Instruments; Systole; Vasodilation | 2018 |
Influence of the TLR4-mediated p38MAPK signaling pathway on chronic intermittent hypoxic-induced rat's oxidative stress and inflammatory cytokines in rats.
Topics: Adipose Tissue; Animals; Antioxidants; Chronic Disease; Cyclic N-Oxides; Cytokines; Disease Models, Animal; Drugs, Chinese Herbal; Humans; Hypoxia; Imidazoles; Male; MAP Kinase Signaling System; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Pyridines; Rats; Rats, Sprague-Dawley; Sleep Apnea, Obstructive; Spin Labels; Toll-Like Receptor 4 | 2019 |
The influence of p38 mitogen-activated protein kinase inhibitor on synthesis of inflammatory cytokine tumor necrosis factor alpha in spinal cord of rats with chronic constriction injury.
Topics: Animals; Chronic Disease; Constriction, Pathologic; Cytokines; Imidazoles; Male; p38 Mitogen-Activated Protein Kinases; Pyridines; Rats; Rats, Sprague-Dawley; Sciatic Neuropathy; Spinal Cord; Tumor Necrosis Factor-alpha | 2007 |